InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Zausner Meryl. Director active across 1 company, notably Seres Therapeutics, Inc.. Aggregated, 1 reports have been published. Activity tracked since 5 July 2022. The latest transaction was disclosed on 5 July 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条